Scarica l'app Stockscreener
121.87
3.06%
3.62
Dopo l'orario di chiusura:
121.80
-0.07
-0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché A Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$118.25
Aprire:
$119.47
Volume 24 ore:
4.01M
Relative Volume:
1.82
Capitalizzazione di mercato:
$34.44B
Reddito:
$7.07B
Utile/perdita netta:
$1.29B
Rapporto P/E:
26.87
EPS:
4.5355
Flusso di cassa netto:
$993.00M
1 W Prestazione:
+5.92%
1M Prestazione:
+8.09%
6M Prestazione:
-14.13%
1 anno Prestazione:
+18.92%
Intervallo 1D:
$118.88
$121.93
Intervallo di 1 settimana:
$114.67
$121.93
Portata 52W:
$99.12
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Nome
Agilent Technologies Inc
Settore
Industria
Telefono
(408) 345-8886
Indirizzo
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
121.87 | 34.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
TMO
Thermo Fisher Scientific Inc
|
526.60 | 195.70B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.75 | 137.82B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
589.25 | 46.80B | 4.30B | 1.06B | 1.04B | 13.08 |
WAT
Waters Corp
|
327.77 | 32.18B | 3.17B | 642.63M | 516.49M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-20 | Iniziato | HSBC Securities | Buy |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-08 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-17 | Downgrade | UBS | Buy → Neutral |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-31 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Reiterato | Barclays | Equal Weight |
| 2023-05-24 | Reiterato | BofA Securities | Buy |
| 2023-05-24 | Reiterato | Citigroup | Neutral |
| 2023-05-24 | Reiterato | Credit Suisse | Outperform |
| 2023-05-24 | Reiterato | Evercore ISI | Outperform |
| 2023-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Reiterato | Robert W. Baird | Outperform |
| 2023-05-24 | Reiterato | SVB Securities | Outperform |
| 2023-05-24 | Reiterato | Stifel | Hold |
| 2023-05-24 | Reiterato | TD Cowen | Outperform |
| 2023-05-24 | Reiterato | Wells Fargo | Overweight |
| 2023-05-11 | Iniziato | Barclays | Equal Weight |
| 2023-01-10 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2022-07-08 | Downgrade | Citigroup | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Reiterato | BofA Securities | Buy |
| 2022-02-23 | Reiterato | Citigroup | Buy |
| 2022-02-23 | Reiterato | Cowen | Outperform |
| 2022-02-23 | Reiterato | Evercore ISI | Outperform |
| 2022-02-23 | Reiterato | Stifel | Hold |
| 2022-02-23 | Reiterato | Wells Fargo | Overweight |
| 2021-11-23 | Reiterato | BofA Securities | Buy |
| 2021-11-23 | Reiterato | Cowen | Outperform |
| 2021-11-23 | Reiterato | Stifel | Hold |
| 2021-03-18 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-25 | Aggiornamento | UBS | Neutral → Buy |
| 2020-11-17 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Iniziato | Atlantic Equities | Neutral |
| 2020-08-19 | Reiterato | BofA Securities | Neutral |
| 2020-08-19 | Reiterato | Citigroup | Neutral |
| 2020-08-19 | Reiterato | Jefferies | Buy |
| 2020-08-19 | Reiterato | Robert W. Baird | Outperform |
| 2020-08-19 | Reiterato | SVB Leerink | Outperform |
| 2020-08-19 | Reiterato | Stifel | Hold |
| 2020-08-19 | Reiterato | Wells Fargo | Overweight |
| 2020-02-24 | Downgrade | Needham | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-11-26 | Reiterato | Needham | Buy |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | UBS | Buy → Neutral |
| 2019-07-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Downgrade | Barclays | Overweight → Equal Weight |
Mostra tutto
Agilent Technologies Inc Borsa (A) Ultime notizie
Agilent Stock Performance & Valuation Analysis 2026 | Business ReviewNews and Statistics - IndexBox
Agilent Technologies Inc (A) Stock Up 3.1% and Still Undervalued -- GF Score: 93/100 - GuruFocus
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent bets on pathology innovation with Biocare acquisition - MSN
Agilent Technologies Inc. stock outperforms competitors despite losses on the day - MarketWatch
Agilent Technologies, Inc. $A Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
TRADE NEWS: Agilent Technologies Introduces HaloPlex Next-Generation Sequencing Panels Targeting Can - Yahoo
Agilent Technologies, Inc. (NYSE:A) Q4 2025 Earnings Call Transcript - MSN
Agilent Technologies Inc stock (US00846U1016): Why its life sciences leadership matters more now for - AD HOC NEWS
Agilent (A) Showcases Innovations at AACR 2026 Annual Meeting - GuruFocus
Agilent Ekes Higher Ahead of Cancer Research Conference - Baystreet.ca
Agilent Showcases Cancer Research Solutions at AACR 2026 - PharmiWeb.com
Sumitomo Mitsui Trust Group Inc. Trims Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
Assetmark Inc. Acquires 12,984 Shares of Agilent Technologies, Inc. $A - MarketBeat
MML Mid Cap Growth Fund's Agilent Technologies Inc(A) Holding History - GuruFocus
Barclays Cuts Agilent Technologies (NYSE:A) Price Target to $140.00 - MarketBeat
Agilent Technologies Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Barclays Adjusts Price Target on Agilent Technologies to $140 From $150, Maintains Overweight Rating - marketscreener.com
Barclays Maintains Agilent Technologies(A.US) With Buy Rating, Cuts Target Price to $140 - Moomoo
Agilent Technologies (A) Valuation Check After CRISPR Patent Loss And BioTek Cytation 9 Launch - Sahm
Agilent Technologies Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Chromatograph (Labor): Precision Tools Drive Agilent's Lab Market Edge Amid Tech Boom - AD HOC NEWS
TD Cowen Adjusts Price Target on Agilent Technologies to $147 From $157, Maintains Buy Rating - marketscreener.com
Is Agilent Technologies Inc impacted by rising ratesTrade Entry Report & AI Enhanced Execution Alerts - baoquankhu1.vn
TRADE NEWS: Agilent Technologies to Demonstrate Leading-Edge RF/Microwave Design and Test Solutions - Yahoo
Massachusetts Financial Services Co. MA Raises Stock Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) to acquire Biocare Medical for $950M - MSN
Agilent Technologies Q1 2026 earnings preview - MSN
TRADE NEWS: Agilent Technologies and Shimadzu to Exchange Chromatography Instrument Drivers - Yahoo
Agilent Technologies Adjusts Valuation Amid Strong Financial Metrics and Market Confidence - Markets Mojo
Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - GlobeNewswire Inc.
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Agilent Technologies and BaseSolve Informatics Announce Co-Marketing Agreement to Deliver An Integrated NGS Workflow in the United States - Sangri Today
DNA Sequencing Market Leading Players AnalysisAbbott - openPR.com
Agilent Technologies, Inc. $A Shares Bought by CCLA Investment Management - MarketBeat
How New Diagnostic Win and Patent Loss Will Impact Agilent Technologies (A) Investors - Sahm
Agilent Technologies Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Oak Thistle LLC Takes $3.46 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Integrated Breakthrough: Agilent and BaseSolve Enhance U.S. Genomics Workflow - Devdiscourse
Agilent Technologies and BaseSolve Informatics partner to offer integrated NGS workflow in the U.S. - ET Edge Insights
Indo-Asian News Service - IANS
Agilent Technologies And Texmin–IIT (ISM) Dhanbad Partner To Advance India’s Critical Minerals And Sustainable Mining Innovation. - TRIPURA STAR NEWS
Agilent Technologies, Inc. (A) stock price, news, quote and history - Yahoo Finance UK
T. Rowe Price Mid-Cap Growth Fund, Inc.'s Agilent Technologies Inc(A) Holding History - GuruFocus
Agilent Opens Customer Experience Center in Mumbai - eHealth Magazine
T. Rowe Price Mid-Cap Growth Portfolio's Agilent Technologies Inc(A) Holding History - GuruFocus
Agilent Technologies, Inc. $A Shares Sold by Brown Shipley& Co Ltd - MarketBeat
Do Options Traders Know Something About Agilent Technologies Stock We Don't? - MSN
Agilent CLO Departing With Severance After Less Than 2 Years in Role - Law.com
Evercore ISI Adjusts Agilent Technologies Price Target to $140 From $160, Maintains Outperform Rating - marketscreener.com
Agilent Technologies Severance Agreement with Bret DiMarco: Key Terms, Release of Claims, and Executive Transition Details - Minichart
Agilent Technologies Inc Azioni (A) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Agilent Technologies Inc Azioni (A) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gonsalves Rodney | V.P., Corporate Controller |
Nov 26 '25 |
Sale |
154.99 |
3,000 |
464,956 |
31,846 |
2.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):